全文获取类型
收费全文 | 1020篇 |
免费 | 59篇 |
专业分类
1079篇 |
出版年
2023年 | 2篇 |
2022年 | 12篇 |
2021年 | 20篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 26篇 |
2017年 | 21篇 |
2016年 | 41篇 |
2015年 | 55篇 |
2014年 | 52篇 |
2013年 | 84篇 |
2012年 | 98篇 |
2011年 | 84篇 |
2010年 | 58篇 |
2009年 | 64篇 |
2008年 | 56篇 |
2007年 | 51篇 |
2006年 | 46篇 |
2005年 | 50篇 |
2004年 | 48篇 |
2003年 | 32篇 |
2002年 | 41篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 12篇 |
1998年 | 14篇 |
1997年 | 11篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1978年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有1079条查询结果,搜索用时 15 毫秒
111.
Gary Tresadern Jose María Cid Gregor J. Macdonald Juan Antonio Vega Ana Isabel de Lucas Aránzazu García Encarnación Matesanz María Lourdes Linares Daniel Oehlrich Hilde Lavreysen Ilse Biesmans Andrés A. Trabanco 《Bioorganic & medicinal chemistry letters》2010,20(1):175-179
Imidazo[1,2-a]pyridines were identified via their shape and electrostatic similarity as novel positive allosteric modulators of the metabotropic glutamate 2 receptor. The subsequent synthesis and SAR are described. Potent, selective and metabolically stable compounds were found representing a promising avenue for current further studies. 相似文献
112.
Echeverri Lina Maria Salazar Moraes Julio Cesar de Lourdes Borba Magalhães Maria Da Silva Gustavo Felippe 《International journal of peptide research and therapeutics》2021,27(1):1-7
International Journal of Peptide Research and Therapeutics - A peptide Phage Display library was constructed using the BTK2 toxin as scaffold and rolling cycle amplification combined with Kunkel... 相似文献
113.
Nitschke Y Baujat G Botschen U Wittkampf T du Moulin M Stella J Le Merrer M Guest G Lambot K Tazarourte-Pinturier MF Chassaing N Roche O Feenstra I Loechner K Deshpande C Garber SJ Chikarmane R Steinmann B Shahinyan T Martorell L Davies J Smith WE Kahler SG McCulloch M Wraige E Loidi L Höhne W Martin L Hadj-Rabia S Terkeltaub R Rutsch F 《American journal of human genetics》2012,90(1):25-39
Spontaneous pathologic arterial calcifications in childhood can occur in generalized arterial calcification of infancy (GACI) or in pseudoxanthoma elasticum (PXE). GACI is associated with biallelic mutations in ENPP1 in the majority of cases, whereas mutations in ABCC6 are known to cause PXE. However, the genetic basis in subsets of both disease phenotypes remains elusive. We hypothesized that GACI and PXE are in a closely related spectrum of disease. We used a standardized questionnaire to retrospectively evaluate the phenotype of 92 probands with a clinical history of GACI. We obtained the ENPP1 genotype by conventional sequencing. In those patients with less than two disease-causing ENPP1 mutations, we sequenced ABCC6. We observed that three GACI patients who carried biallelic ENPP1 mutations developed typical signs of PXE between 5 and 8 years of age; these signs included angioid streaks and pseudoxanthomatous skin lesions. In 28 patients, no disease-causing ENPP1 mutation was found. In 14 of these patients, we detected pathogenic ABCC6 mutations (biallelic mutations in eight patients, monoallelic mutations in six patients). Thus, ABCC6 mutations account for a significant subset of GACI patients, and ENPP1 mutations can also be associated with PXE lesions in school-aged children. Based on the considerable overlap of genotype and phenotype of GACI and PXE, both entities appear to reflect two ends of a clinical spectrum of ectopic calcification and other organ pathologies, rather than two distinct disorders. ABCC6 and ENPP1 mutations might lead to alterations of the same physiological pathways in tissues beyond the artery. 相似文献
114.
115.
Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53 总被引:1,自引:0,他引:1
Moneo V Serelde BG Fominaya J Leal JF Blanco-Aparicio C Romero L Sánchez-Beato M Cigudosa JC Tercero JC Piris MA Jimeno J Carnero A 《Journal of cellular biochemistry》2007,100(2):339-348
Yondelis (Trabectedin, ET-743) is a marine anticancer agent currently in Phase II/III development in patients with advanced pretreated soft tissue sarcoma. In the present study, we generated a panel of low passaged tumor cell lines from samples explanted from chemonaive sarcoma patients with different tumor types. We assessed in vitro sensitivity/resistance to Trabectedin and doxorubicin in a panel of sarcoma cell lines and examined the correlation between molecular alterations in DNA repair genes and sensitivity to Trabectedin. We treated cell lines with Trabectedin and doxorubicin in both 96-h and clonogenic assays. In both assays, well-defined groups of resistant and sensitive cell lines were observed. Resistance to Trabectedin did not correlate with resistance to doxorubicin, indicating that the two drugs may have different mechanisms of resistance. p53 mutations and deletions correlated with extreme sensitivity (IC50 < 1 nM) to Trabectedin (P < 0.01). In a pair of isogenic cell lines differing only in the presence or absence of wild-type p53, the absence of p53 rendered cells threefold more sensitive to Trabectedin. 相似文献
116.
Martín JA Brooks DA Prieto L González R Torrado A Rojo I López de Uralde B Lamas C Ferritto R Dolores Martín-Ortega M Agejas J Parra F Rizzo JR Rhodes GA Robey RL Alt CA Wendel SR Zhang TY Reifel-Miller A Montrose-Rafizadeh C Brozinick JT Hawkins E Misener EA Briere DA Ardecky R Fraser JD Warshawsky AM 《Bioorganic & medicinal chemistry letters》2005,15(1):51-55
Herein we describe a series of potent and selective PPARgamma agonists with moderate PPARalpha affinity and little to no affinity for other nuclear receptors. In vivo studies in a NIDDM animal model (ZDF rat) showed that these compounds are efficacious at low doses in glucose normalization and plasma triglyceride reduction. Compound 1b (LY519818) was selected from our SAR studies to be advanced to clinical evaluation for the treatment of type II diabetes. 相似文献
117.
Goldman AS Guisinger VH Aikins M Amarillo ML Belizario VY Garshong B Gyapong J Kabali C Kamal HA Kanjilal S Kyelem D Lizardo J Malecela M Mubyazi G Nitièma PA Ramzy RM Streit TG Wallace A Brady MA Rheingans R Ottesen EA Haddix AC 《PLoS neglected tropical diseases》2007,1(1):e67
Background
Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ivermectin), a multicenter study was undertaken to determine the costs of MDA programs to interrupt transmission of infection with LF. Such results are particularly important because LF programs have the necessary diagnostic and treatment tools to eliminate the disease as a public health problem globally, and already by 2006, the Global Programme to Eliminate LF had initiated treatment programs covering over 400 million of the 1.3 billion people at risk.Methodology/Principal Findings
To obtain annual costs to carry out the MDA strategy, researchers from seven countries developed and followed a common cost analysis protocol designed to estimate 1) the total annual cost of the LF program, 2) the average cost per person treated, and 3) the relative contributions of the endemic countries and the external partners. Costs per person treated ranged from $0.06 to $2.23. Principal reasons for the variation were 1) the age (newness) of the MDA program, 2) the use of volunteers, and 3) the size of the population treated. Substantial contributions by governments were documented – generally 60%–90% of program operation costs, excluding costs of donated medications.Conclusions/Significance
MDA for LF elimination is comparatively inexpensive in relation to most other public health programs. Governments and communities make the predominant financial contributions to actual MDA implementation, not counting the cost of the drugs themselves. The results highlight the impact of the use of volunteers on program costs and provide specific cost data for 7 different countries that can be used as a basis both for modifying current programs and for developing new ones. 相似文献118.
E. Richard Lourdes R. Desviat Belén Pérez Celia Pérez-Cerdá M. Ugarte 《Human genetics》1997,101(1):93-96
Propionyl-CoA carboxylase (PCC) is a mitochondrial, biotin-dependent enzyme involved in the catabolism of branched chain
amino acids, odd chain fatty acids, and other metabolites. PCC consists of non-identical subunits, α and β, encoded by the
PCCA and PCCB genes, respectively. Inherited deficiency of PCC due to mutations in either the PCCA or the PCCB gene results
in propionic acidemia (PA), a clinically heterogeneous disorder with a severe, often lethal, neonatal form, and a mild, later
onset form. To characterize PCCA gene mutations responsible for PCC deficiency, we analyzed RT-PCR products obtained from
cultured fibroblasts from Spanish PCC-α deficient patients. In three patients, smaller than normal PCR products were observed,
and sequence analysis revealed the deletion of a 54-bp exon in the cDNA. Sequencing of genomic DNA from these three patients
led to the identification of three novel mutations in the PCCA gene, two short deletions and one small insertion, adjacent
to short direct repeats, and all of them affecting the consensus splice sites of the skipped exon. These mutations, 1771IVS-2del9,
1824IVS+3del4, and 1824IVS+3insCT, are the cause of the aberrant splicing of the PCCA pre-mRNA and result in an in-frame deletion
of 54 nucleotides in the cDNA, probably leading to an unstable protein structure which is responsible for the lack of activity
leading to PCC deficiency in these patients.
Received: 6 June 1997 / Accepted: 14 July 1997 相似文献
119.
H. George Wang Robert D. Owen † Cornelio Sánchez-Hernández‡ María De Lourdes Romero-Almaraz§ 《Global Ecology and Biogeography》2003,12(1):65-85
Aim To investigate the relationship between chiropteran species distributions and four fundamental environmental factors — temperature, precipitation, soil and vegetation — and to construct a species richness prediction map based on the environmental factors. Location The state of Michoacán, México. Methods Bat specimens collected during a 2‐year project were combined with museum specimens to form a dataset of over 3200 entries pertaining to 71 species of bats. Coordinates of the collection localities were recorded with GPS receivers or determined from maps. ArcView GIS was used to characterize the distribution of the species relative to the four environmental factors by projecting coordinates of the collection sites onto digitized maps of those factors. Correspondence analysis (CA) was used to evaluate the relationship between species distributions and the environmental factors. Results The CA results indicated that the order of importance of these factors is (from highest to lowest): temperature, vegetation, precipitation and soil. A predicted distribution map was constructed for each species of bat, based on the result of the CA analysis, using correspondences of each species to climate, vegetation and precipitation. Soil types were excluded from the prediction model because soil type does not appear to carry high predictive value for bat species in Michoacán. Distribution maps of the 71 bat species were then overlaid to generate a map of bat species richness for the state of Michoacán. Main conclusions Neither family membership nor feeding guild affiliation appear to play important roles in chiropteran species distributions in Michoacán. The bat species richness prediction map will be a useful tool for conservation works in the region. 相似文献
120.
Thais Graziela Donegá França Larissa Lumi Watanabe Ishikawa Sofia Fernanda Gonçalves Zorzella-Pezavento Fernanda Chiuso-Minicucci Clara Pires Fujiara Guerino de Lourdes Ribeiro de Souza Maria da Cunha Alexandrina Sartori 《BMC microbiology》2009,9(1):240-7